[go: up one dir, main page]

JOP20190275A1 - طرق وتركيبات لعلاج اضطراب إسهال خِلقي - Google Patents

طرق وتركيبات لعلاج اضطراب إسهال خِلقي

Info

Publication number
JOP20190275A1
JOP20190275A1 JOP/2019/0275A JOP20190275A JOP20190275A1 JO P20190275 A1 JOP20190275 A1 JO P20190275A1 JO P20190275 A JOP20190275 A JO P20190275A JO P20190275 A1 JOP20190275 A1 JO P20190275A1
Authority
JO
Jordan
Prior art keywords
disorder
compositions
methods
treating congenital
diarrhea
Prior art date
Application number
JOP/2019/0275A
Other languages
English (en)
Inventor
A Conte Lisa
R Chaturvedi Pravin
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of JOP20190275A1 publication Critical patent/JOP20190275A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

غير متوفر
JOP/2019/0275A 2017-05-31 2017-06-16 طرق وتركيبات لعلاج اضطراب إسهال خِلقي JOP20190275A1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762513251P 2017-05-31 2017-05-31

Publications (1)

Publication Number Publication Date
JOP20190275A1 true JOP20190275A1 (ar) 2019-11-27

Family

ID=64455032

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2019/0275A JOP20190275A1 (ar) 2017-05-31 2017-06-16 طرق وتركيبات لعلاج اضطراب إسهال خِلقي

Country Status (12)

Country Link
US (2) US11857510B2 (ar)
EP (1) EP3634581B8 (ar)
JP (1) JP2020525407A (ar)
CN (1) CN110831667A (ar)
AU (1) AU2018278312B2 (ar)
CA (1) CA3065797A1 (ar)
DK (1) DK3634581T3 (ar)
ES (1) ES2988850T3 (ar)
FI (1) FI3634581T3 (ar)
IL (1) IL270984A (ar)
JO (1) JOP20190275A1 (ar)
WO (1) WO2018222919A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3564370D1 (en) 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
KR100467532B1 (ko) 1996-10-16 2005-01-24 피에스 팔마큐티칼스 인코퍼레이션 프로안토시아니딘 중합체로 된 항-설사 장용피 조제물
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
AU2007248182B2 (en) 2006-05-01 2013-05-23 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
EP2529626B1 (en) 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
CA2777214A1 (en) * 2009-10-06 2011-04-14 The Regents Of The University Of California Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
JP6063385B2 (ja) 2010-10-31 2017-01-18 ナポ ファーマシューティカルズ インコーポレイテッド Ｈｉｖ関連の下痢を治療するための方法および組成物
US20180338932A1 (en) * 2015-12-23 2018-11-29 Dmitry Kravtsov Compositions and methods of treatment for mvid and related diseases
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة

Also Published As

Publication number Publication date
US20240325346A1 (en) 2024-10-03
US20200108047A1 (en) 2020-04-09
EP3634581A4 (en) 2021-02-24
CA3065797A1 (en) 2018-12-06
WO2018222919A1 (en) 2018-12-06
EP3634581B1 (en) 2024-07-31
DK3634581T3 (da) 2024-08-26
ES2988850T3 (es) 2024-11-21
AU2018278312A1 (en) 2020-01-02
US11857510B2 (en) 2024-01-02
JP2020525407A (ja) 2020-08-27
FI3634581T3 (fi) 2024-08-16
AU2018278312B2 (en) 2024-07-04
IL270984A (en) 2020-01-30
CN110831667A (zh) 2020-02-21
EP3634581B8 (en) 2024-09-11
EP3634581A1 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
CY1124215T1 (el) Μκ2 αναστολεις και χρησεις αυτων
CL2018000947S1 (es) Automóvil
CL2018002782A1 (es) Apósito modificado
GEP20217234B (en) Pyridopyrimdinone cdk2/4/6 inhibitors
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
ECSP18008905A (es) Tricíclicos sustituidos y método para usarlos.
CL2017001393S1 (es) Automovil
CL2017001185S1 (es) Automovil
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
AU2016263598A8 (en) Methods and kits for treating depression
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
CL2018001940S1 (es) Automóvil
PH12018502137A1 (en) Anti-complement factor bb antibodies and uses thereof
JOP20190267A1 (ar) مثبطات بيرازول magl
MX2019010984A (es) Composiciones de sintecina y metodos de uso.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX382996B (es) Inhibidores de pcna
PH12017501864A1 (en) Compositions and methods for treating autism
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
IL282824A (en) Preparations and methods for treating transient biofilms
ZA201907283B (en) Compositions, devices and methods for treating autism
CL2018000791S1 (es) Automóvil
IL277463A (en) Vehicles and methods for treating itch
JOP20210036A1 (ar) مثبطات او- جليكوبروتين-2-أسيتاميدو-2-ديوكسي-3-دي-جلوكوبيرانوسيداز